Fresenius Kabi (FRE.DE)
Quick facts
| Ticker | FRE.DE (Frankfurt Stock Exchange) |
|---|
Marketed products
- Nesacaine-Mpf · Pain
- Compounded standard parenteral nutrition
- Heparin Sodium In Plastic Container · Cardiovascular
Heparin enhances Antithrombin III activity to inhibit coagulation factors Xa and IIa. - Dilaudid-Hp · Neuroscience
Hydromorphone binds primarily to mu-opioid receptors, producing analgesia without a ceiling effect. - Dilaudid-Hp · Neuroscience
Full mu-opioid receptor agonist providing analgesia through CNS opioid receptor activation. - Ionolyte · Other
- Ketosteril®
- Lactulose crystals 30 g
- Lactulose liquid 20 g
- Unithroid · Oncology
Unithroid works by replacing or supplementing the thyroid hormone thyroxine, which is produced by the thyroid gland. - Lignospan Forte · Neuroscience
Lidocaine stabilizes neuronal membrane by inhibiting ionic fluxes required for impulse initiation and conduction. - Bloxiverz · Neuroscience
Bloxiverz works by blocking the enzyme acetylcholinesterase, allowing more acetylcholine to be available in the nervous system. - Oxytocin 5 Usp Units In Dextrose 5% · Neuroscience
- Pentam · Metabolic
Pentamidine works by interfering with the reproduction of certain parasites, such as Pneumocystis jiroveci. - Diprivan · Neuroscience
Propofol produces sedative/anesthetic effects by positive modulation of inhibitory GABA function through GABA A receptors. - Zemuron · Neuroscience
Zemuron works by blocking the action of acetylcholine at the neuromuscular junction, preventing muscle contraction. - Naropin · Pain
- SmofKabiven® E
- Perikabiven In Plastic Container · Metabolic
- Tygacil · Infectious Disease
Tygacil works by binding to the 30S ribosomal subunit of bacteria, preventing the aminoacyl-tRNA from binding and thereby inhibiting protein synthesis. - Volulyte 6%
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: